Effects of growth hormone on cardiac dysfunction and gene expression in genetic murine dilated cardiomyopathy

Basic Research in Cardiology

Volumn 95, Issue 6, 2000, Pages 431-441

  Hongo, M ^a   Ryoke, T ^a   Schoenfeld, J ^a   Hunter, J ^a   Dalton, N ^a   Clark, R ^a   Lowe, D ^a   Chien, K ^a   Ross, J ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Gene disruption; Gene knockout; Heart failure; Left ventricular function; Muscle LIM protein

Indexed keywords

GROWTH HORMONE; MESSENGER RNA; MUSCLE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GROWTH HORMONE BLOOD LEVEL; HEART DILATATION; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE RELAXATION; HORMONE ACTION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN;

ANIMALS; BODY WEIGHT; CARDIOMYOPATHY, DILATED; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; GENE EXPRESSION; GROWTH HORMONE; HEART; HEMODYNAMIC PROCESSES; MICE; MICE, KNOCKOUT; MUSCLE PROTEINS; MYOCARDIUM; ORGAN SIZE; VENTRICULAR FUNCTION, LEFT;

EID: 0034532276     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003950070018     Document Type: Article

References (36)

1. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy
2. Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation
3. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure
4. Variability in the quantitation of circulating growth hormone using commercial immunoassays
5. Genes and physiology: Molecular physiology in genetically engineered animals
6. Stress pathways and heart failure
7. Cardiovascular effects of growth hormone treatment in growth-hormone-deficient adults: Stimulation of the renin-aldosterone system
8. Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat
9. IGF-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure
10. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy
11. Estimation of somatomedin-C levels in normal and patients with pituitary disease by radioimmunoassay
12. Recombinant growth hormone therapy in patients with ischemic cardiomyopathy: Effects of hemodynamics, left ventricular function, and cardiopulmonary exercise capacity
13. A novel method for real time quantitative RT-PCR
14. Species specificity of the primate growth hormone receptor
15. Angiotensin II blockade followed by growth hormone as adjunctive therapy after experimental myocardial infarction
16. Models of Cardiac Disease in the Mouse
17. Models of dilated cardiomyopathy in the mouse and the hamster
18. Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition
19. The causes of dilated cardiomyopathy: A clinicopathologic review of 673 consecutive patients
20. The left ventricular dP/dt max-end-diastolic volume relation in closed chest dogs
21. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure
22. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy
23. Brief report: Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy
24. Identification of the Syrian hamster cardiomyopathy gene
25. Randomized, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy
26. Force-frequency effect is a powerful determinant of myocardial contractility in the mouse
27. Volume loading shows left ventricular isovolumic relaxation rate: Evidence of load-dependent relaxation in the intact dog heart
28. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene targeted mice
29. Growth hormone, cardiomyocyte contractile reserve, and heart failure
30. Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and ACE inhibition
31. Growth hormone and the heart
32. Distinct molecular phenotypes in cardiac muscle development, growth and hypertrophy
33. Transthoracic echocardiography in models of cardiac disease in the mouse
34. Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy and gene expression in mice
35. 2+ release channels (ryanodine receptors) and enhances cardiac function in cardiomyopathic hamsters
36. Growth hormone improves cardiac performance in experimental heart failure